FindTrial
Sign In

The clinical epidemiological characteristics and immune status of CSF in patients with Cryptococcal meningitis in Zhejiang Province, China.

The clinical epidemiological characteristics and immune status of CSF in patients with Cryptococcal meningitis in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-17014004
Enrollment
Unknown
Registered
2017-12-17
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cryptococcal meningitis

Interventions

at lest 4 groups:anti-Cryptococcus treatment

Sponsors

the First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) previously or newly diagnosed CM patients; 2) first hospitalized patients; 3) above 18 years old; and 4) agree to accept anti-Cryptococcus treatment; 5) able to give consent.

Exclusion criteria

Exclusion criteria: 1) repeatedly hospitalized patients; 2) Stay time less than 7 days due to reassess healthy condition; 3)refused ant-Cryptococcus treatment.

Design outcomes

Primary

MeasureTime frame
Cryptococcal meningitis related mortality;—

Countries

China

Contacts

Public ContactLijun Xu

The First Affiliated Hospital, School of Medicine, Zhejiang University.

xulijun1976@zju.edu.cn+86 13757108324

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026